A. Spira

Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized discontinuation trial.

Maha Hussain, Matthew Ryan Smith, C. Sweeney et al. · Journal of Clinical Oncology · 2011 · 110 citations

Medicine, Oncology, Pharmacology +17

460MO Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers

Komal Jhaveri, Hyo S. Han, Efrat Dotan et al. · Annals of Oncology · 2022 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease.

A M Duliege, Antoine Messiah, Stéphane Blanche et al. · PubMed · 1992 · 51 citations

Medicine, Infectious Diseases, Pediatrics +14

MA03.02 TROPION-PanTumor01: Updated Results From the NSCLC Cohort of the Phase 1 Study of Datopotamab Deruxtecan in Solid Tumors

Edward B. Garon, Melissa L. Johnson, Aaron Lisberg et al. · Journal of Thoracic Oncology · 2021 · 25 citations

Medicine, Oncology, Pharmacology +8

Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited.

Jöel Coste, A. Spira, D Clerc et al. · PubMed · 1997 · 23 citations

Medicine, Immunology, Aging +16